The key aim was to establish suitable analytical targets by analyzing human hepatocyte incubation samples with significant-resolution mass spectrometry (HRMS) and to confirm the final results in genuine urine specimens and to ascertain AB-FUBINACA's metabolic steadiness in human liver microsomes and in contrast hepatocyte and urine effects with in